ICAM1 and thyroid gland carcinoma: Studies have found that ICAM-1 is overexpressed in different types of cancer13, including thyroid cancer, and has associated it with aggressive features such as extrathyroidal extension, lymph node metastasis, and BRAFV600E mutation14–16.